| __timestamp | Corcept Therapeutics Incorporated | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 882000 | 176081000 |
| Thursday, January 1, 2015 | 1361000 | 157939000 |
| Friday, January 1, 2016 | 2058000 | 164073000 |
| Sunday, January 1, 2017 | 3554000 | 169243000 |
| Monday, January 1, 2018 | 5215000 | 168489000 |
| Tuesday, January 1, 2019 | 5504000 | 172526000 |
| Wednesday, January 1, 2020 | 5582000 | 200649000 |
| Friday, January 1, 2021 | 5281000 | 237513000 |
| Saturday, January 1, 2022 | 5385000 | 353358000 |
| Sunday, January 1, 2023 | 6481000 | 586886000 |
Unlocking the unknown
In the evolving landscape of the healthcare sector, understanding cost structures is crucial. Over the past decade, Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated have shown distinct trajectories in their cost of revenue. From 2014 to 2023, Lantheus Holdings experienced a staggering 233% increase in costs, peaking at nearly $587 million in 2023. This reflects their aggressive expansion and scaling efforts. In contrast, Corcept Therapeutics saw a more modest growth of 635% in the same period, reaching approximately $6.5 million in 2023. This indicates a more controlled cost management strategy. The data highlights the contrasting business models and growth strategies of these two companies, offering valuable insights for investors and industry analysts alike.
Comparing Cost of Revenue Efficiency: Johnson & Johnson vs Lantheus Holdings, Inc.
Cost of Revenue Comparison: Johnson & Johnson vs Corcept Therapeutics Incorporated
Cost of Revenue: Key Insights for AbbVie Inc. and Lantheus Holdings, Inc.
Analyzing Cost of Revenue: Teva Pharmaceutical Industries Limited and Corcept Therapeutics Incorporated
Insmed Incorporated vs Corcept Therapeutics Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Cost of Revenue Comparison: Pharming Group N.V. vs Lantheus Holdings, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Grifols, S.A.
Cost Insights: Breaking Down Lantheus Holdings, Inc. and Mesoblast Limited's Expenses
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Geron Corporation
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc.